Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
57.4M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$2.65B
-
Value change
-
+$50M
-
Put/Call ratio
-
0.37
-
Number of buys
-
90
-
Number of sells
-
-91
-
Price
-
$46.11
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q4 2018
237 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2018.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.4M shares
of 58.6M outstanding shares and own 97.96% of the company stock.
Largest 10 shareholders include FMR LLC (8.73M shares), WELLINGTON MANAGEMENT GROUP LLP (8.14M shares), Vanguard Group Inc (4.62M shares), BlackRock Inc. (3.32M shares), Capital International Investors (3.23M shares), BB BIOTECH AG (2.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.35M shares), Woodford Investment Management Ltd (1.98M shares), STATE STREET CORP (1.65M shares), and Clearbridge Investments, LLC (1.5M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.